Growth Metrics

Bruker (BRKRP) Current Deferred Revenue (2016 - 2025)

Bruker's Current Deferred Revenue history spans 16 years, with the latest figure at $550.4 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 2.27% year-over-year to $550.4 million; the TTM value through Dec 2025 reached $550.4 million, up 2.27%, while the annual FY2025 figure was $550.4 million, 2.27% up from the prior year.
  • Current Deferred Revenue reached $550.4 million in Q4 2025 per BRKRP's latest filing, up from $455.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $590.8 million in Q1 2024 to a low of $175.5 million in Q3 2022.
  • Average Current Deferred Revenue over 5 years is $423.3 million, with a median of $435.3 million recorded in 2021.
  • Peak YoY movement for Current Deferred Revenue: surged 176.98% in 2021, then plummeted 56.19% in 2022.
  • A 5-year view of Current Deferred Revenue shows it stood at $197.5 million in 2021, then surged by 138.84% to $471.7 million in 2022, then fell by 15.2% to $400.0 million in 2023, then surged by 34.55% to $538.2 million in 2024, then grew by 2.27% to $550.4 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Current Deferred Revenue are $550.4 million (Q4 2025), $455.4 million (Q3 2025), and $478.1 million (Q2 2025).